Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technology

Journal of Clinical Virology

Volumn 69, Issue , 2015, Pages 165-171

  Laiho, Jutta E ^a   Oikarinen, Sami ^a   Oikarinen, Maarit ^a   Larsson, Pär G ^b   Stone, Virginia M ^b   Hober, Didier ^c   Oberste, Steven ^d   Flodström Tullberg, Malin ^b   Isola, Jorma ^e   Hyöty, Heikki ^a,f  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b KAROLINSKA INSTITUTE   (Sweden)

^c University Lille   (France)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e Institute of Biosciences and Medical Technology   (Finland)

^f PIRKANMAA HOSPITAL DISTRICT   (Finland)

Author keywords

Enterovirus; In situ hybridization; Probe design; Type 1 diabetes

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; CONSENSUS SEQUENCE; CONTROLLED STUDY; CROSS REACTION; ENTEROVIRUS INFECTION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; KIDNEY CELL; MOUSE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; RHABDOMYOSARCOMA CELL; SEROTYPE; VIRUS DETECTION; ANALYSIS; ANIMAL; BIOLOGY; CELL LINE; CHLOROCEBUS AETHIOPS; CLASSIFICATION; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; GENETICS; HELA CELL LINE; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PROCEDURES; RNA PROBE; SENSITIVITY AND SPECIFICITY; VERO CELL LINE; VIROLOGY;

RNA PROBE; VIRUS RNA;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; COMPUTATIONAL BIOLOGY; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; HELA CELLS; HUMANS; IN SITU HYBRIDIZATION; MICE; MOLECULAR DIAGNOSTIC TECHNIQUES; PANCREAS; RNA PROBES; RNA, VIRAL; SENSITIVITY AND SPECIFICITY; VERO CELLS;

EID: 84937948736     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.06.085     Document Type: Article

References (21)

1. Abzug M.J. The enteroviruses: Problems in need of treatments. J Infect. 2014, 68:S108-S114.
2. Oyero O.G., Adu F.D., Ayukekbong J.A. Molecular characterization of diverse species enterovirus-B types from children with acute flaccid paralysis and asymptomatic children in nigeria. Virus Res. 2014, 189(0):189-193.
3. Messacar K., Schreiner T.L., Maloney J.A., et al. A cluster of acute flaccid paralysis and cranial nerve dysfunction temporally associated with an outbreak of enterovirus D68 in children in colorado, USA. Lancet 2015, 10.1016/S0140-6736(14) 62.457-0(0).
4. Bonnin A., Tassin M., Vauloup-Fellous C., et al. Case of a healthy infant born following antenatal enterovirus myocarditis and hydrops. J. Clin. Virol. 2014, 61(3):459-462.
5. Kindermann I., Barth C., Mahfoud F., et al. Update on myocarditis. J. Am. Coll. Cardiol. 2012, 59(9):779-792.
6. Hyöty H., Hiltunen M., Lönnrot M. Enterovirus infections and insulin dependent diabetes mellitus-evidence for causality. Clin. Diagn. Virol. 1998, 9(2-3):77-84.
7. Morgan N.G., Richardson S.J. Enteroviruses as causative agents in type 1 diabetes: loose ends or lost cause. Trends Endocrinol. Metab. 2014, 25(12):611-619.
8. Jaidane H., Sauter P., Sane F., Goffard A., Gharbi J., Hober D. Enteroviruses and type 1 diabetes: towards a better understanding of the relationship. Rev. Med. Virol. 2010, 20(5):265-280.
9. Sane F., Caloone D., Gmyr V., et al. Coxsackievirus B4 can infect human pancreas ductal cells and persist in ductal-like cell cultures which results in inhibition of Pdx1 expression and disturbed formation of islet-like cell aggregates. Cell Mol. Life Sci. 2013, 70(21):4169-4180.
10. Laitinen O.H., Honkanen H., Pakkanen O., et al. Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes. 2014, 63(2):446-455.
11. Oikarinen S., Tauriainen S., Hober D., et al. Virus antibody survey in different european populations indicates risk association between coxsackievirus B1 and type 1 diabetes. Diabetes 2014, 63(2):655-662.
12. Samuelson A., Forsgren M., Sallberg M. Characterization of the recognition site and diagnostic potential of an enterovirus group-reactive monoclonal-antibody. Clin. Diagn. Lab. Immunol. 1995, 2(3):385-386.
13. Hansson S.F., Korsgren S., Ponten F., Korsgren O. Enteroviruses and the pathogenesis of type 1 diabetes revisited: Cross-reactivity of enterovirus capsid protein (VP1) antibodies with human mitochondrial proteins. J. Pathol. 2013, 229(5):719-728.
14. Hansson S.F., Korsgren S., Ponten F., Korsgren O. Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry?. Diabetologia 2014, 57(3):645-646.
15. Richardson S., Leete P., Dhayal S., et al. Evaluation of the fidelity of immunolabelling obtained with clone 5D8 /1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas. Diabetologia 2014, 57(2):392-401.
16. Richardson S.J., Leete P., Dhayal S., et al. Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry? reply to hansson SF, korsgren S, ponten F et al. [letter]. Diabetologia 2014, 57(3):647-649.
17. Wang F., Flanagan J., Su N., et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. J. Mol. Diagn. 2012, 14(1):22-29.
18. Oikarinen M., Tauriainen S., Oikarinen S., et al. Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes 2012, 61(3):687-691.
19. Flodstrom-Tullberg M., Hultcrantz M., Stotland A., et al. R. Nase L. and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection. J. Immunol. 2005, 174(3):1171-1177.
20. Tuominen V.J., Isola J. The application of JPEG2000 in virtual microscopy. J. Digital Imaging. 2009, 22(3):250-258.
21. Oikarinen M., Tauriainen S., Penttila P., et al. Evaluation of immunohistochemistry and in situ hybridization methods for the detection of enteroviruses using infected cell culture samples. J. Clin. Virol. 2010, 47(3):224-228.